发明名称 Tablet featurated by controllable release of alphusozine hydrochloride contained therein
摘要 Tablets for oral administration comprise a) a first layer 1 that swells noticeably and rapidly on contact with aqueous biological fluids, the layer being prepared by compression of a mixture or granules having 5 - 90% by weight (pref. 10 - 85%) of hydrophilic polymers, b) a second layer 2 that is adjacent to or superposed on 1, containing alfuzosin hydrochloride (I), hydrophilic polymers, and auxiliary materials that give the mixture compressibility whilst allowing liberation of (I) over a predetermined period, and optionally c) a third layer 3 that is compressed and applied over 2 which is mainly hydrophilic polymers that gel and/or swell and which may erode, having the effect of modifying liberation of (I) from layer 2, this layer 3 being only slightly permeable to (I) these tablets giving controlled liberation of (I) at the proximal segments of the gastrointestinal tract (duodenum and jejunum).
申请公布号 PL191546(B1) 申请公布日期 2006.06.30
申请号 PL19970331862 申请日期 1997.08.22
申请人 SANOFI-AVENTIS;JAGOTEC AG. 发明人 MAGGI LAURETTA;CONTE UBALDO;GRENIER PASCAL;VERGNAULT GUY;DUFOUR ALAIN;JARREAU FRANCOIS XAVIER;RAUCH-DESANTI CLEMENCE
分类号 A61K9/22;A61K31/517;A61K9/20;A61K9/24;A61K31/505;A61P13/08 主分类号 A61K9/22
代理机构 代理人
主权项
地址